Browse by popular tags
abvd act acute lymphoblastic leukaemia acute myelogenous leukemia (aml) acute myeloid leukaemia ade admire adoptive cellular therapy after 2 prior treatments alemtuzumab all allogeneic allogeneic stem cell transplant aml aml 17 angioimmunoblastic lymphoma antiviral therapy arctic autologous stem cell transplant autologous transplant autologus stem cell transplant azacitidine b-cell b-cell chronic lymphocytic leukaemia bevacizumab bexarotene blood cancers blood transfusions bone marrow
NHS Logo
The Clinical research facility is part of the NIHR and is funded by the Department of Health
The AML16 Trial will evaluate several relevant therapeutic questions in Acute Myeloid Leukaemia (AML), as defined by the WHO, and High Risk Myelodysplastic Syndrome. The trial is primarily designed for patients over 60 years, but younger patients who may not be considered suitable for the concurrent MRC AML Trial for
younger patients may also enter.